B7H3 (CD276) Rabbit Polyclonal Antibody
CAT#: TA355034
Rabbit Polyclonal Anti-CD276 Antibody
Need it in bulk or conjugated?
Get a free quote
CNY 5,808.00
Cited in 1 publication. |
CNY 300.00
CNY 1,430.00
CNY 9,998.00
CNY 3,080.00
Specifications
Product Data | |
Applications | IF, IHC, WB |
Recommend Dilution | WB: 0.5-1µg/mL.IHC: 2µg/mL. Immunoflorescence start at 20µg/mL. |
Reactivity | Human, Mouse, Rat |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | CD276 antibody was raised against a peptide corresponding to 19 amino acids near the carboxy terminus of CD276. The immunogen is located within amino acids 484 - 534 of CD276. |
Formulation | CD276 Antibody is supplied in PBS containing 0.02% sodium azide. |
Concentration | 1 mg/ml |
Purification | CD276 Antibody is affinity chromatography purified via peptide column. |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | Predicted: 35, 43, 57 kDa; Observed: 59 kDa |
Gene Name | CD276 molecule |
Database Link | |
Background | CD276, also known as B7-H3, was initially identified as a member of the B7 family of proteins through its homology with previously identified B7 molecules (1). CD276 mRNA is widely expressed, but its protein expression is usually rather low (2). CD276 has been shown to play a role in both the costimulation as well as the coinhibition of T cell response (3). In a similar fashion, CD276 plays a critical role in the control of antitumor immune responses in some cases, while in others appears to mediate antitumor immunity (4). It thus joins other immune checkpoint proteins as a possible therapeutic target for at least a subset of cancers. |
Synonyms | 4Ig-B7-H3; B7-H3; B7H3 |
Note | CD276 antibody can be used for Western blot at 0.5 - 1 µg/mL. Antibody can also be used for Immunohistochemistry at 2 µg/mL. For Immunoflorescence start at 20 µg/mL. |
Reference Data |
Citations (1)
The use of this Antibodies has been cited in the following citations: |
---|
The expressions and significance of B7-H3 and CTLA-4 in the clinical stages of non-small-cell lung cancer
,Liu, Z;Pei, M;Liu, J;Shi, F;Zhang, Y;Zhao, D;Li, J;Guo, F;Yan, J;Liu, J;Li, Y;,
International Journal of Experimental Pathology
[CD276]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |